Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1999. Start Trial.
Date Value
October 27, 2026 5.264
October 26, 2026 4.962
October 23, 2026 4.403
October 22, 2026 4.458
October 21, 2026 4.391
October 20, 2026 4.345
October 19, 2026 4.092
October 16, 2026 3.952
October 15, 2026 4.058
October 14, 2026 4.213
October 13, 2026 4.296
October 12, 2026 4.414
October 09, 2026 4.511
October 08, 2026 4.246
October 07, 2026 4.368
October 06, 2026 4.405
October 05, 2026 4.636
October 02, 2026 4.643
October 01, 2026 4.583
September 30, 2026 4.576
September 29, 2026 4.513
September 28, 2026 4.625
September 25, 2026 4.640
September 24, 2026 4.697
September 23, 2026 4.940
Date Value
September 22, 2026 5.194
September 21, 2026 5.130
September 18, 2026 5.217
September 17, 2026 5.369
September 16, 2026 5.139
September 15, 2026 5.065
September 14, 2026 5.270
September 11, 2026 5.075
September 10, 2026 5.035
September 09, 2026 5.027
September 08, 2026 5.181
September 04, 2026 5.082
September 03, 2026 4.999
September 02, 2026 5.034
September 01, 2026 5.060
August 31, 2026 5.088
August 28, 2026 5.007
August 27, 2026 5.304
August 26, 2026 5.463
August 25, 2026 5.594
August 24, 2026 5.627
August 21, 2026 5.931
August 20, 2026 5.761
August 19, 2026 6.026
August 18, 2026 6.212

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Tenax Therapeutics, Inc. 0.4838
Exicure, Inc. 6.981
Century Therapeutics, Inc. 1.127
Absci Corp. 7.368
Celularity, Inc. --

Price to Book Value Related Metrics

Price 95.81
Earnings Yield -2.57%
Market Cap 5.851B